Wednesday, September 29


Alzheimer's, alzheimer's drugs, BI Commentary, FDA, Healthcare, Mental Health, OpiniĆ³n, permalancer, Politics, Public Health, Science, SSRI

The FDA is broken. It’s controversial approval of an ineffective new Alzheimer’s drug proves the agency puts profit over public health.

The agency's approval of a new Alzheimer's drug rightly caused an uproar. But the problems extend far beyond the drug, and far beyond the FDA: Drug science has been corrupted by the pharmaceutical industry. We must get money out of science to have safe and effective drugs. PE Moskowitz is an author and runs Mental Hellth, a newsletter about capitalism and psychology. This is an opinion article. The thoughts expressed are those of the author. LoadingSomething is loading. ...